Company Filing History:
Years Active: 2014
Title: Samara Hantman: Innovator in Transdermal Drug Delivery Systems
Introduction
Samara Hantman is a notable inventor based in Miami, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. Her innovative work has the potential to enhance the effectiveness of drug administration.
Latest Patents
Hantman holds a patent for a transdermal drug delivery system specifically designed for diclofenac. The patent discloses a transdermal composition that utilizes a pharmaceutically acceptable acid or salt form of diclofenac in combination with a pharmaceutically acceptable adhesive matrix carrier. In her preferred embodiment, diclofenac is present as both the free acid and potassium salt form within the adhesive matrix composition, along with a dual permeation enhancer. This innovative adhesive matrix composition is applied in a method that significantly increases drug delivery for 24 hours or more.
Career Highlights
Samara Hantman is currently associated with Noven Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at Noven has positioned her as a key player in the pharmaceutical industry, focusing on innovative drug delivery solutions.
Collaborations
Hantman collaborates with various professionals in her field, including her coworker David Houze. Their combined expertise contributes to the advancement of pharmaceutical technologies and enhances the impact of their research.
Conclusion
Samara Hantman's contributions to transdermal drug delivery systems exemplify her commitment to innovation in the pharmaceutical industry. Her patent for a diclofenac delivery system showcases her ability to develop effective solutions that can improve patient care.